WCA
SNY icon

Whetstone Capital Advisors’s Sanofi SNY Stock Holding History

Whetstone Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278K Buy
5,774
+1,020
+21% +$47.6K 0.1% 30
2025
Q4 		$230K Sell
4,754
-137
-3% -$6.79K 0.07% 31
2025
Q3 		$231K Buy
+4,891
New +$236K 0.06% 42

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Whetstone Capital Advisors's SNY Position: Q1 2026 in Review

Whetstone Capital Advisors increased its Sanofi (SNY) stake by 21% in Q1 2026, buying an estimated $47.6K and bringing the position to 5,774 shares worth $278K. The position accounts for 0.1% of the portfolio, ranked #30.

Whetstone Capital Advisors first reported a position in SNY in Q3 2025 and has held it in 3 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Whetstone Capital Advisors held 5,774 shares of Sanofi worth $278K as of Q1 2026.
  • Whetstone Capital Advisors bought 1,020 Sanofi shares in Q1 2026, an estimated $47.6K.
  • Sanofi made up 0.1% of Whetstone Capital Advisors's portfolio in Q1 2026, its #30 holding.
  • Whetstone Capital Advisors first reported a position in Sanofi in Q3 2025 and has held it in 3 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Whetstone Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.